Femara

Femara (Letrozole) is a medication used to treat certain types of breast cancer in postmenopausal women. It works by reducing estrogen levels in the body, which can help slow the growth of cancer cells. This oral medication is commonly prescribed for hormone receptor-positive breast cancer.

Femara is primarily used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. It is often prescribed for early-stage breast cancer after surgery and for advanced breast cancer. The medication works by inhibiting the enzyme aromatase, which reduces the production of estrogen. This can help slow the progression of cancer cells that rely on estrogen to grow.

Common effects of Femara may include hot flashes, joint pain, fatigue, and hair thinning. Some users may also experience nausea, headache, or dizziness. These effects vary from person to person and are not experienced by everyone who takes the medication.

Femara should be used with caution in individuals with a history of osteoporosis or liver disease. It is important to discuss any pre-existing conditions with a healthcare provider before starting this medication. Regular monitoring may be recommended to assess bone health and liver function.

Femara may interact with certain medications, including estrogen-containing therapies and some types of antidepressants. It is important to inform a healthcare provider about all medications being taken to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare provider.